drugset / Press release
Hanmi Pharmaceutical’s Combination Drug for Dyslipidemia Treatment, ‘Rosuzet’: Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in ‘The Lancet’ & ‘European Heart Journal’
2023-03-22 · Hanmi Pharmaceutical Company Limited · original hanmipharm.com ↗
Hanmi Pharmaceutical’s Combination Drug for Dyslipidemia Treatment, ‘Rosuzet’: Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in ‘The Lancet’ & ‘European Heart Journal’
The release as fetched from its publisher. hanmipharm.com ↗